AlphaYouRVMD: Anders Jack discloses a sale
By AlphaYouPublished Form 4
Anders Jack
Reporting filer
Anders Jack reported Sale in Revolution Medicines, Inc.: 61 units of Common Stock, dated 2026-09-16. The full Form 4 contains 2 transaction entries.
- Disclosed
- Sep 18, 2026
Reported details
2 entries| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Anders Jack | 2026-09-16 | S | Sale | 61 | 195 | 123,208 | 2 days | Filed terms
|
| Common Stock | Anders Jack | 2026-09-16 | S | Sale | 3992 | 199.3032 | 119,216 | 2 days | Filed terms
|
Common Stock
- Owner
- Anders Jack
- Date
- 2026-09-16
- Code
- S
- Action
- Sale
- Quantity
- 61
- Price
- 195
- Following holdings
- 123,208
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-09-16
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: false
- id: F1
- transaction Shares: 61
- transaction Price Per Share: 195
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 123208
- direct Or Indirect Ownership: D
Common Stock
- Owner
- Anders Jack
- Date
- 2026-09-16
- Code
- S
- Action
- Sale
- Quantity
- 3992
- Price
- 199.3032
- Following holdings
- 119,216
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-09-16
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: false
- id: F1
- transaction Shares: 3992
- transaction Price Per Share: 199.3032
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 119216
- id: F2
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Anders Jack: Chief Financial Officer.
- The filing reports a Rule 10b5-1 trading plan.
- F1: Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units.
- F2: Includes 43,650 restricted stock units.
Original sources
Prepared automatically from public filing data. Report a correction.